Clinical trials
Melanoma trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
| Completed | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Regeneron Pharmaceuticals | 2 |
| Sandoz | 2 |
| Biocon Biologics UK PLC | 1 |
| Formycon AG | 1 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Shanghai Henlius Biotech | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 12 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Hepatocellular | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Skin Neoplasms | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.